Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 299

2.

Metabolism of estrone sulfate by normal breast tissue: influence of menopausal status and oral contraceptives.

Söderqvist G, Olsson H, Wilking N, von Schoultz B, Carlström K.

J Steroid Biochem Mol Biol. 1994 Feb;48(2-3):221-4.

PMID:
8142298
3.

Markedly elevated levels of estrone sulfate after long-term oral, but not transdermal, administration of estradiol in postmenopausal women.

Slater CC, Hodis HN, Mack WJ, Shoupe D, Paulson RJ, Stanczyk FZ.

Menopause. 2001 May-Jun;8(3):200-3.

PMID:
11355042
4.
5.

Comparison of estrogen and androgen levels after oral estrogen replacement therapy.

Slater CC, Zhang C, Hodis HN, Mack WJ, Boostanfar R, Shoupe D, Paulson RJ, Stanczyk FZ.

J Reprod Med. 2001 Dec;46(12):1052-6.

PMID:
11789085
6.

Estrone sulfate, estrone and estradiol concentrations in normal and cirrhotic postmenopausal women.

Jasonni VM, Bulletti C, Bolelli GF, Franceschetti F, Bonavia M, Ciotti P, Flamigni C.

Steroids. 1983 May;41(5):569-73.

PMID:
6318400
7.

Effects of hormone therapy on estrogen synthesis from E1S in the mammary gland of postmenopausal women.

Stute P, Szuwart T, Schlueter M, Götte M, Packeisen J, Kiesel L.

Maturitas. 2008 Feb 20;59(2):163-73. doi: 10.1016/j.maturitas.2007.12.005.

PMID:
18261865
8.

An optimised, highly sensitive radioimmunoassay for the simultaneous measurement of estrone, estradiol and estrone sulfate in the ultra-low range in human plasma samples.

Geisler J, Ekse D, Helle H, Duong NK, Lønning PE.

J Steroid Biochem Mol Biol. 2008 Mar;109(1-2):90-5. doi: 10.1016/j.jsbmb.2007.12.011.

PMID:
18242079
9.

Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators.

Geisler J.

J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):245-53. Review.

PMID:
14623518
10.
11.

Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancer.

Dixon JM, Renshaw L, Young O, Murray J, Macaskill EJ, McHugh M, Folkerd E, Cameron DA, A'Hern RP, Dowsett M.

J Clin Oncol. 2008 Apr 1;26(10):1671-6. doi: 10.1200/JCO.2007.13.9279.

PMID:
18375896
12.

Influence of plasma estrogen levels on the length of the disease-free interval in postmenopausal women with breast cancer.

Lønning PE, Helle SI, Johannessen DC, Ekse D, Adlercreutz H.

Breast Cancer Res Treat. 1996;39(3):335-41.

PMID:
8877014
13.

Low endogenous estrogen levels--analytical problems and tissue sensitivity.

Carlström K.

Acta Obstet Gynecol Scand Suppl. 1996;163:11-5. Review.

PMID:
8916470
14.
15.
16.

Hemodialysis and estrogen levels in postmenopausal (HELP) patients: The multicenter HELP study.

Kramer HM, Curhan G, Singh A; HELP Study Group..

Am J Kidney Dis. 2003 Jun;41(6):1240-6.

PMID:
12776277
17.

Estrone/17beta-estradiol conversion to, and tumor necrosis factor inhibition by, estrogen metabolites in synovial cells of patients with rheumatoid arthritis and patients with osteoarthritis.

Schmidt M, Hartung R, Capellino S, Cutolo M, Pfeifer-Leeg A, Straub RH.

Arthritis Rheum. 2009 Oct;60(10):2913-22. doi: 10.1002/art.24859.

18.

Relationship between aromatase activity and steroid receptor levels in ovarian tumors from postmenopausal women.

Noguchi T, Kitawaki J, Tamura T, Kim T, Kanno H, Yamamoto T, Okada H.

J Steroid Biochem Mol Biol. 1993 Mar;44(4-6):657-60.

PMID:
8476778
19.

Origin of serum estradiol in postmenopausal women.

Judd HL, Shamonki IM, Frumar AM, Lagasse LD.

Obstet Gynecol. 1982 Jun;59(6):680-6.

PMID:
7078905
20.
Items per page

Supplemental Content

Support Center